BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
BioRestorative Therapies, Inc. (BRTX)
NASDAQ:AMEX Investor Relations:
biorestorative.com/content/investor-relations
Company Research
Source: GlobeNewswire
– Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints – – Patient reported efficacy outcomes show a material decrease in pain and increase in function – – If positive trends continue, Company confident that the Phase 2 trial will meet its Primary and Secondary end points - – The blinded preliminary BRTX-100 data to be described in a podium presentation this morning at the ORS PSRS 7th International Spine Research Symposium – – Webcasted conference call also scheduled for today at 4:30pm EST – MELVILLE, N.Y., Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced new preliminary 26–52 week blinded data from the first 10 patients with chronic lumbar disc disease (“cLDD”) enrolled in the ongoing Phase 2 clinical trial of BRTX-100. BRTX-100, a no
Show less
Read more
Impact Snapshot
Event Time:
BRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRTX alerts
High impacting BioRestorative Therapies, Inc. news events
Weekly update
A roundup of the hottest topics
BRTX
News
- BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
- BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research SymposiumGlobeNewswire
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health [Yahoo! Finance]Yahoo! Finance
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of HealthGlobeNewswire
BRTX
Sec Filings
- 11/14/24 - Form SCHEDULE
- 11/13/24 - Form 8-K
- 11/13/24 - Form S-8
- BRTX's page on the SEC website